AS 2646
Alternative Names: AD-2646; AS-2646Latest Information Update: 14 Jun 2000
At a glance
- Originator Dainippon Pharmaceutical
- Class Antiulcers
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Peptic ulcer
Most Recent Events
- 14 Jun 2000 Discontinued-II for Peptic ulcer in Japan (PO)